References
- AAPOR. (2016). The American Association for Public Opinion Research. Standard definitions: Final dispositions of case codes and outcome rates for surveys. (9th ed.). https://www.aapor.org/AAPOR_Main/media/publications/Standard-Definitions20169theditionfinal.pdf
- Abrams, D. I. (2018). The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report. European Journal of Internal Medicine, 49, 7–11. https://doi.org/https://doi.org/10.1016/j.ejim.2018.01.003
- APA. (2013). American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5TM. (5th ed.). Arlington, VA: American Psychiatric Publishing Inc.
- Black, N., Stockings, E., Campbell, G., Tran, L. T., Zagic, D., Hall, W. D., Farrell, M., & Degenhardt, L. (2019). Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. The Lancet. Psychiatry, 6(12), 995–1010. https://doi.org/https://doi.org/10.1016/S2215-0366(19)30401-8
- Bollom, A., Austrie, J., Hirsch, W., Nee, J., Friedlander, D., Iturrino, J., Ballou, S., & Lembo, A. (2018). Emergency department burden of nausea and vomiting associated with cannabis use disorder: US trends from 2006 to 2013. Journal of Clinical Gastroenterology, 52(9), 778–783. https://doi.org/https://doi.org/10.1097/MCG.0000000000000944
- Bon-Miller, M., Boden, M., Bucossi, M., & Babson, K. (2014). Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. The American Journal of Drug and Alcohol Abuse, 40(1), 23–30.
- Botsford, S. L., Yang, S., & George, T. P. (2020). Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential. The American Journal on Addictions, 29(1), 9–26. https://doi.org/https://doi.org/10.1111/ajad.12963
- Brezing, C. A., Choi, C. J., Pavlicova, M., Brooks, D., Mahony, A. L., Mariani, J. J., & Levin, F. R. (2018). Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment-seekers with cannabis use disorder. American Journal on Addictions, 27(2), 101–107. https://doi.org/https://doi.org/10.1111/ajad.12660
- Brook, J. S., Lee, J. Y., Finch, S. J., Seltzer, N., & Brook, D. W. (2013). Adult work commitment, financial stability, and social environment as related to trajectories of marijuana use beginning in adolescence. Substance Abuse, 34(3), 298–305. https://doi.org/https://doi.org/10.1080/08897077.2013.775092
- CCHS (2018). Canadian Community Health Survey Information. https://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=3226&lang=en&db=imdb&adm=8&dis=2
- CCS (2018). Canadian Cannabis Survey 2018 Summary. https://www.canada.ca/en/services/health/publications/drugs-health-products/canadian-cannabis-survey-2018-summary
- Cousijn, J., Núñez, A. E., & Filbey, F. M. (2018). Time to acknowledge the mixed effects of cannabis on health: a summary and critical review of the NASEM 2017 report on the health effects of cannabis and cannabinoids. Addiction (Abingdon, England), 113(5), 958–966. https://doi.org/https://doi.org/10.1111/add.14084
- Crippa, J. A., Zuardi, A. W., Martín-Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar-Poli, P. (2009). Cannabis and anxiety: A critical review of the evidence. In Human Psychopharmacology. https://doi.org/https://doi.org/10.1002/hup.1048
- Desai, R., Fong, H. K., Shah, K., Kaur, V. P., Savani, S., Gangani, K., Damarlapally, N., & Goyal, H. (2019). Rising trends in hospitalizations for cardiovascular events among young cannabis users (18–39 years) without other substance abuse. Medicina (Lithuania). Medicina, 55(8), 438. https://doi.org/https://doi.org/10.3390/medicina55080438
- Di Forti, M., Iyegbe, C., Sallis, H., Kolliakou, A., Falcone, M. A., Paparelli, A., Sirianni, M., La Cascia, C., Stilo, S. A., Marques, T. R., Handley, R., Mondelli, V., Dazzan, P., Pariante, C., David, A. S., Morgan, C., Powell, J., & Murray, R. M. (2012). Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biological Psychiatry, 72(10), 811–816. https://doi.org/https://doi.org/10.1016/j.biopsych.2012.06.020
- Di Forti, M., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., Rodriguez, V., Jongsma, H. E., Ferraro, L., La Cascia, C., La Barbera, D., Tarricone, I., Berardi, D., Szöke, A., Arango, C., Tortelli, A., Velthorst, E., Bernardo, M., Del-Ben, C. M., … van der Ven, E. (2019). The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. The Lancet Psychiatry, 6(5), 427–436. https://doi.org/https://doi.org/10.1016/S2215-0366(19)30048-3
- Evans, S., Banerjee, S., Leese, M., & Huxley, P. (2007). The impact of mental illness on quality of life: A comparison of severe mental illness, common mental disorder and healthy population samples. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 16(1), 17–29. https://doi.org/https://doi.org/10.1007/s11136-006-9002-6
- Feingold, D., Rehm, J., & Lev-Ran, S. (2017). Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study. Psychiatry Research, 251, 225–234. https://doi.org/https://doi.org/10.1016/j.psychres.2017.02.027
- Gage, S. H., Hickman, M., & Zammit, S. (2016). Association between cannabis and psychosis: Epidemiologic evidence. Biological Psychiatry, 79(7), 549–556. https://doi.org/https://doi.org/10.1016/j.biopsych.2015.08.001
- Gage, S. H., Jones, H. J., Burgess, S., Bowden, J., Davey Smith, G., Zammit, S., & Munafò, M. R. (2017). Assessing causality in associations between cannabis use and schizophrenia risk: A two-sample Mendelian randomization study. Psychological Medicine, 47(5), 971–980. https://doi.org/https://doi.org/10.1017/S0033291716003172
- Gentes, E. L., Schry, A. R., Hicks, T. A., Clancy, C. P., Collie, C. F., Kirby, A. C., Dennis, M. F., Hertzberg, M. A., Beckham, J. C., & Calhoun, P. S. (2016). Prevalence and correlates of cannabis use in an outpatient VA posttraumatic stress disorder clinic. Psychology of Addictive Behaviors, 30(3), 415–421. https://doi.org/https://doi.org/10.1037/adb0000154
- Gibbs, M., Winsper, C., Marwaha, S., Gilbert, E., Broome, M., & Singh, S. P. (2015). Cannabis use and mania symptoms: A systematic review and meta-analysis. Journal of Affective Disorders, 171, 39–47. https://doi.org/https://doi.org/10.1016/j.jad.2014.09.016
- Gobbi, G., Atkin, T., Zytynski, T., Wang, S., Askari, S., Boruff, J., Ware, M., Marmorstein, N., Cipriani, A., Dendukuri, N., & Mayo, N. (2019). Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: A systematic review and meta-analysis. JAMA Psychiatry, 76(4), 426. https://doi.org/https://doi.org/10.1001/jamapsychiatry.2018.4500
- Goldenberg, M., IsHak, W. W., & Danovitch, I. (2017). Quality of life and recreational cannabis use. The American Journal on Addictions, 26(1), 8–25. https://doi.org/https://doi.org/10.1111/ajad.12486
- Goodman, S., & Hammond, D. (2018). International Cannabis Policy Study. Technical Report - Wave, 1, pp. 13–20. http://cannabisproject.ca/methods/
- Goodman, S., & Hammond, D. (2020). International Cannabis Policy Study Code Book–Wave. 1 (2018). p. 5. http://cannabisproject.ca/wp-content/uploads/2014/05/ICPS-CODE-BOOK-2018-Sept-2-2020.pdf
- Goodman, S., Wadsworth, E., Leos-Toro, C., & Hammond, D. (2020). Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets. International Journal of Drug Policy, 76, 102658. https://doi.org/https://doi.org/10.1016/j.drugpo.2019.102658
- Government of Canada (2017). Canadian Tobacco, Alcohol and Drugs Survey (CTADS): summary of results for 2017. https://www.canada.ca/en/health-canada/services/canadian-alcohol-drugs-survey/2017-summary.html
- Grucza, R. A., Agrawal, A., Krauss, M. J., Cavazos-Rehg, P. A., & Bierut, L. J. (2016). Recent trends in the prevalence of marijuana use and associated disorders in the United States. JAMA Psychiatry, 73(3), 300. https://doi.org/https://doi.org/10.1001/jamapsychiatry.2015.3111
- Hall, K. E., Monte, A. A., Chang, T., Fox, J., Brevik, C., Vigil, D. I., Van Dyke, M., & James, K. A. (2018). Mental Health–related Emergency Department Visits Associated With Cannabis in Colorado. Academic Emergency Medicine, 25(5), 526–537. https://doi.org/https://doi.org/10.1111/acem.13393
- Hammond, D., Goodman, S., Wadsworth, E., Rynard, V., Boudreau, C., & Hall, W. (2020a). Evaluating the impact of cannabis legalization: The International Cannabis Policy Study. International Journal of Drug Policy, 77, 102698. https://doi.org/https://doi.org/10.1016/j.drugpo.2020.102698
- Hammond, D., Goodman, S., Wadsworth, E., Rynard, V., Boudreau, C., & Hall, W. (2020b). Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study. International Journal of Drug Policy, 77, 102698. https://doi.org/https://doi.org/10.1016/j.drugpo.2020.102698
- Hosseini, S., & Oremus, M. (2019). The effect of age of initiation of cannabis use on psychosis, depression, and anxiety among youth under 25 years. Canadian Journal of Psychiatry, 64(5), 304–312. https://doi.org/https://doi.org/10.1177/0706743718809339
- Kedzior, K. K., & Laeber, L. T. (2014). A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population- a meta-analysis of 31 studies. BMC Psychiatry, 14(1), 1–22. https://doi.org/https://doi.org/10.1186/1471-244X-14-136
- Koob, G. F., & Le Moal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 24(2), 97–129. https://doi.org/https://doi.org/10.1016/S0893-133X(00)00195-0
- Lev-Ran, S., Roerecke, M., Le Foll, B., George, T. P., McKenzie, K., & Rehm, J. (2014). The association between cannabis use and depression: A systematic review and meta-analysis of longitudinal studies. Psychological Medicine, 44(4), 797–810. https://doi.org/https://doi.org/10.1017/S0033291713001438
- Lev-Ran, S., Le Foll, B., McKenzie, K., George, T. P., & Rehm, J. (2013). Bipolar disorder and co-occurring cannabis use disorders: Characteristics, co-morbidities and clinical correlates. Psychiatry Research, 209(3), 459–465. https://doi.org/https://doi.org/10.1016/j.psychres.2012.12.014
- Lev-Ran, S., Le Foll, B., McKenzie, K., & Rehm, J. (2012). Cannabis use and mental health-related quality of life among individuals with anxiety disorders. Journal of Anxiety Disorders, 26(8), 799–810. https://doi.org/https://doi.org/10.1016/j.janxdis.2012.07.002
- Lim, K., See, Y. M., & Lee, J. (2017). A systematic review of the effectiveness of medical cannabis for psychiatric, movement and neurodegenerative disorders. Clinical Psychopharmacology and Neuroscience: The Official Scientific Journal of the Korean College of Neuropsychopharmacology, 15(4), 301–312. https://doi.org/https://doi.org/10.9758/cpn.2017.15.4.301
- Lowe, D. J. E., Sasiadek, J. D., Coles, A. S., & George, T. P. (2019). Cannabis and mental illness: A review. In European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/https://doi.org/10.1007/s00406-018-0970-7
- MacDonald, S., Hall, W., Roman, P., Stockwell, T., Coghlan, M., & Nesvaag, S. (2010). Testing for cannabis in the work-place: A review of the evidence. In Addiction. https://doi.org/https://doi.org/10.1111/j.1360-0443.2009.02808.x
- Maloney-Hall, B., Wallingford, S. C., Konefal, S., & Young, M. M. (2020). Psychotic disorder and cannabis use: Canadian hospitalization trends, 2006–2015. Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice, 40(5/6), 176–183. https://doi.org/https://doi.org/10.24095/hpcdp.40.5/6.06
- Mammen, G., Rueda, S., Roerecke, M., Bonato, S., Lev-Ran, S., & Rehm, J. (2018). Association of cannabis with long-term clinical symptoms in anxiety and mood disorders: A systematic review of prospective studies. Journal of Clinical Psychiatry, 79(4), 17r11839. https://doi.org/https://doi.org/10.4088/JCP.17r11839
- Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016). Meta-Analysis of the association between the level of cannabis use and risk of psychosis. Schizophrenia Bulletin, 42(5), 1262–1269. https://doi.org/https://doi.org/10.1093/schbul/sbw003
- McGuckin, T., Ferro, M., Hammond, D., Steward, S., Maloney-Hall, B., Madi, N., Porath, A., & Perlman, C. (2020). How high? Trends in cannabis use prior to first admission to inpatient psychiatry in Ontario, Canada between 2007 and 2017. Canadian Journal of Psychiatry, 66(12), 1059–1068.
- Metrik, J., Rohsenow, D., Monti, P., McGeary, J., Cook, T., de Wit, H., Haney, M., & Kahler, C. (2009). Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. Experimental and Clinical Psychopharmacology, 17(4), 217–225.
- Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet, 370(9584):319–328. https://doi.org/https://doi.org/10.1016/S0140-6736(07)61162-3
- Morgan, C. J. A., Freeman, T. P., Powell, J., & Curran, H. V. (2016). AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers. Translational Psychiatry, 6(2), e738–e738. https://doi.org/https://doi.org/10.1038/tp.2015.219
- NASEM. (2017). National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids. The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press.
- Pasman, J., Verweij, K., Gerring, Z., Stringer, S., Sanchez-Roige, S., Treur, J., Abdellaoui, A., Nivard, M., Baselmans, B., Ong, J.-S., Ip, H., van der Zee, M., Bartels, M., Day, F., Fontanillas, P., Elson, S., de Wit, H., Davis, L., MacKillop, J., … Vink, J. (2018). Genome-wide association analysis of lifetime cannabis use (N = 184,765) identifies new risk loci, genetic overlap with mental health, and a causal influence of schizophrenia on cannabis use. BioRxiv, 21(9), 1161–1170 https://doi.org/https://doi.org/10.1101/234294
- Mané, A., Bergé, D., Penzol, M. J., Parellada, M., Bioque, M., Lobo, A., González-Pinto, A., Corripio, I., Cabrera, B., Sánchez-Torres, A. M., Saiz-Ruiz, J., Bernardo, M., & Group, PEPs. (2017). Cannabis use, COMT, BDNF and age at first-episode psychosis. Psychiatry Research, 250, 38–43. https://doi.org/https://doi.org/10.1016/j.psychres.2017.01.045
- SAMHSA (2018). Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSUDH Series H-53). https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHFFR2017/NSDUHFFR2017.pdf
- Schoeler, T., Monk, A., Sami, M. B., Klamerus, E., Foglia, E., Brown, R., Camuri, G., Altamura, A. C., Murray, R., & Bhattacharyya, S. (2016). Continued versus discontinued cannabis use in patients with psychosis: A systematic review and meta-analysis. The Lancet Psychiatry, 3(3), 215–225. https://doi.org/https://doi.org/10.1016/S2215-0366(15)00363-6
- Shearer, F. M., Bailey, P. M., Hicks, B. L., Harvey, B. V., Monterosso, L., Ross-Adjie, G., & Rogers, I. R. (2015). Why do patients choose to attend a private emergency department? Emergency Medicine Australasia: Ema, 27(1), 62–65. https://doi.org/https://doi.org/10.1111/1742-6723.12330
- Statistics Canada (2016). 2016 Census of Population, Statistics Canada Catalogue no. 98-400-X2016242. Highest Certificate, Diploma or Degree. https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/dt-td/Rp-eng.cfm?LANG=E&APATH=3&DETAIL=0&DIM=0&FL=A&FREE=0&GC=0&GID=0&GK=0&GRP=1&PID=110634&PRID=-10&PTYPE=109445&S=0&SHOWALL=0&SUB=0&Temporal=2017&THEME=123&VID=0&VNAMEE=&VNAMEF
- Statistics Canada (2017). Table 17-10-0005-01 Population estimates on July 1st, by age and sex. https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710000501
- Twomey, C. D. (2017). Association of cannabis use with the development of elevated anxiety symptoms in the general population: A meta-analysis. Journal of Epidemiology and Community Health, 71(8), 811–816. https://doi.org/https://doi.org/10.1136/jech-2016-208145
- U.S. Census Bureau (2018a). 2013-2017 American Community Survey 5-Year Estimates. https://www.census.gov/newsroom/press-kits/2018/acs-5year.html
- U.S. Census Bureau (2018b). Population Division. Annual State Resident Population Estimates for 6 Race Groups (5 Race Alone Groups and Two or More Races) by Age, Sex, and Hispanic Origin.: April 1, 2010 to July 1, 2017. https://www.census.gov/newsroom/press-kits/2018/estimates-characteristics.html
- Van Rossum, I., Boomsma, M., Tenback, D., Reed, C., & Van Os, J. (2009). Does cannabis use affect treatment outcome in bipolar disorder?: A longitudinal analysis. Journal of Nervous and Mental Disease, 197(1), 35–40. https://doi.org/https://doi.org/10.1097/NMD.0b013e31819292a6
- Van Winkel, R., Kahn, R. S., Linszen, D. H., Van Os, J., Wiersma, D., Bruggeman, R., Cahn, W., De Haan, L., Krabbendam, L., & Myin-Germeys, I. (2011). Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: Sibling analysis and proband follow-up. Archives of General Psychiatry, 68(2), 148. https://doi.org/https://doi.org/10.1001/archgenpsychiatry.2010.152
- Vaucher, J., Keating, B. J., Lasserre, A. M., Gan, W., Lyall, D. M., Ward, J., Smith, D. J., Pell, J. P., Sattar, N., Paré, G., & Holmes, M. V. (2018). Cannabis use and risk of schizophrenia: A Mendelian randomization study. Molecular Psychiatry, 23(5), 1287–1292. https://doi.org/https://doi.org/10.1038/mp.2016.252
- WHO (2010). The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). https://www.who.int/management-of-substance-use/assist
- Wilkinson, S. T., Radhakrishnan, R., & D’Souza, D. C. (2014). Impact of Cannabis Use on the Development of Psychotic Disorders. Current Addiction Reports, 1(2), 115–128. https://doi.org/https://doi.org/10.1007/s40429-014-0018-7
- Wilkinson, S. T., Stefanovics, E., & Rosenheck, R. A. (2015). Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder. Journal of Clinical Psychiatry, 76(9), 74–1180 https://doi.org/https://doi.org/10.4088/JCP.14m09475
- Zhu, H., & Wu, L. T. (2016). Trends and correlates of cannabis-involved emergency department visits: 2004 to 2011. Journal of Addiction Medicine, 10(6), 429–436. https://doi.org/https://doi.org/10.1097/ADM.0000000000000256